Xeris Biopharma Holdings (0A8E.L) Stock Price
$4.69 1.6%
to add to portfolio
AI Score
-
Alternative
4 -
Fundamental
2 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Xeris Biopharma Holdings, AI stock picks, stock alerts and much more.
0A8E.L AI Stock Analysis
AI stock analysis for 0A8E.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Xeris Biopharma Holdings (0A8E.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Xeris Biopharma Holdings (0A8E.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Xeris Biopharma Holdings (0A8E.L), currently trading at $4.69, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About 0A8E.L
-
Xeris Biopharma Holdings, Inc.
-
Symbol
0A8E.L
-
Market
LSE
-
Industry
Biotechnology
-
Market Cap
751.1M
Similar Stocks
 |
Codexis 0I0X.L |
$2.69 0.7% |
4 |
 |
Oxford Nanopore Technologies plc ONT.L |
£144.7 1.5% |
6 |
 |
Sareum Holdings SAR.L |
£19.75 6% |
6 |
 |
Viridian Therapeutics 0K1R.L |
$15.98 1.9% |
6 |
 |
Avacta Group Plc AVCT.L |
£31.5 1.6% |
2 |
News
0A8E.L Alternative Data
Web Traffic
Xeris Biopharma Holdings receives an estimated 6051 monthly visitors to xerispharma.com.
-
Web Traffic
6051
-
Change from Previous Month
48.6%
-
3 Month Change
29.7%
-
YoY Change
29.7%
Facebook Engagement
Xeris Biopharma Holdings has engaged 0 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
0
-
Daily Change
0%
-
1 Month Change
100%
-
3 Month Change
0%
Instagram Followers
Xeris Biopharma Holdings has 822 Instagram Followers on its main Instagram account, up by 0.4% over the last month.
-
Instagram Followers
822
-
Daily Change
0%
-
1 Month Change
0.4%
-
3 Month Change
0.1%
-
YoY Change
0.1%
Job Postings
Xeris Biopharma Holdings currenly has an estimated 21 open job postings, up by 10.5% over the last month.
-
Job Postings
21
-
Daily Change
0%
-
1 Month Change
10.5%
-
3 Month Change
31.3%
-
YoY Change
31.3%
Reddit Mentions
Xeris Biopharma Holdings has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Twitter Followers
Xeris Biopharma Holdings has 978 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.3% over the last month.
-
Twitter Followers
978
-
Daily Change
0%
-
1 Month Change
0.3%
-
3 Month Change
1.2%
-
YoY Change
1.2%
LinkedIn Followers
23,789 are following Xeris Biopharma Holdings on LinkedIn, up by 2.1% over the last month.
-
LinkedIn Followers
23789
-
Daily Change
2.1%
-
1 Month Change
2.1%
-
3 Month Change
4.3%
-
YoY Change
4.3%
Business Outlook
According to employee reviews, the business outlook among employees at Xeris Biopharma Holdings is 63 out of 100 (bullish), down by -1.6% over the last month.
-
Business Outlook
63
-
Change from Previous Month
1.6%
-
3 Month Change
13.7%
-
YoY Change
13.7%
LinkedIn Employees
According to LinkedIn, Xeris Biopharma Holdings has 419 employees, up by 2.2% over the last month.
-
LinkedIn Employees
419
-
Daily Change
2.2%
-
1 Month Change
2.2%
-
3 Month Change
4.8%
-
YoY Change
4.8%
News Mentions
Xeris Biopharma Holdings was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
0A8E.L Financials
0A8E.L Key Metrics
-
Total Revenue
$60.1M
-
Net Income
-$5.1M
-
Earnings per Share
-$0.0343
-
Free cash flow
$1.8M
-
EBITDA
$5.7M
-
EBITDA Ratio
0.0952262
-
Total Assets
$323.1M
0A8E.L 2-year Revenue & Income
0A8E.L 2-year Free Cash Flow
0A8E.L Technicals
0A8E.L SMA
0A8E.L RSI
FAQ
What's the current price of Xeris Biopharma Holdings (0A8E.L) Stock?
The price of an Xeris Biopharma Holdings (0A8E.L) share is $4.69.
What's the market cap of Xeris Biopharma Holdings?
The current market cap of Xeris Biopharma Holdings is 751.1M.
Should I buy or sell 0A8E.L?
Xeris Biopharma Holdings shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Xeris Biopharma Holdings is better viewed as a hold or accumulate position while waiting for further developments.
Is Xeris Biopharma Holdings a good investment?
The current analysis of Xeris Biopharma Holdings' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Xeris Biopharma Holdings' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Xeris Biopharma Holdings (0A8E.L) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Xeris Biopharma Holdings stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Xeris Biopharma Holdings (0A8E.L) that investors often compare it to?
Xeris Biopharma Holdings (0A8E.L) is often compared to similar stocks such as Codexis, Oxford Nanopore Technologies plc, Sareum Holdings, Viridian Therapeutics and Avacta Group Plc.
What is the forecast for Xeris Biopharma Holdings' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Xeris Biopharma Holdings' stock price to be around $4.56 in 2026. Starting from the current price of $4.69, this represents a 2.8% change in price, indicating a neutral outlook for the stock.
How to buy Xeris Biopharma Holdings (0A8E.L) Stock?
Xeris Biopharma Holdings stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Xeris Biopharma Holdings shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.